Trexquant Investment’s Mesa Laboratories MLAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-18,661
Closed -$1.65M 2100
2026
Q1
$1.65M Sell
18,661
-27,460
-60% -$2.37M 0.01% 1068
2025
Q4
$3.62M Buy
46,121
+21,031
+84% +$1.6M 0.03% 749
2025
Q3
$1.68M Buy
25,090
+21,070
+524% +$1.52M 0.02% 971
2025
Q2
$379K Buy
+4,020
New +$441K ﹤0.01% 1330
2023
Q3
Sell
-2,408
Closed -$309K 1684
2023
Q2
$309K Buy
2,408
+861
+56% +$131K 0.01% 1185
2023
Q1
$270K Buy
+1,547
New +$277K 0.01% 1234
2021
Q2
Sell
-1,796
Closed -$437K 1337
2021
Q1
$437K Buy
1,796
+949
+112% +$261K 0.04% 571
2020
Q4
$243K Buy
+847
New +$233K 0.03% 803

Other funds holding MLAB

Trexquant Investment's MLAB Position: Q2 2026 in Review

Trexquant Investment sold out of Mesa Laboratories (MLAB) in Q2 2026, closing a stake of 18,661 shares — an estimated $1.65M sold.

Trexquant Investment first reported a position in MLAB in Q4 2020 and held it in 8 quarters. The position peaked at $3.62M in Q4 2025. 159 funds tracked by Wall St. Rank hold MLAB as of Q2 2026.

  • Trexquant Investment reported no remaining Mesa Laboratories position as of Q2 2026 after selling out during the quarter.
  • Trexquant Investment sold 18,661 Mesa Laboratories shares in Q2 2026, an estimated $1.65M.
  • Trexquant Investment first reported a position in Mesa Laboratories in Q4 2020 and held it in 8 quarters.
  • Trexquant Investment's Mesa Laboratories position peaked at $3.62M in Q4 2025.
  • 159 funds tracked by Wall St. Rank held Mesa Laboratories as of Q2 2026.

Based on Trexquant Investment's 13F filing for Q2 2026, filed 14 Aug 2026.